Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 37.99%
March 31, 2026 33.80%
December 31, 2025 39.65%
September 30, 2025 37.95%
June 30, 2025 35.50%
March 31, 2025 34.96%
December 31, 2024 40.33%
September 30, 2024 37.97%
June 30, 2024 31.95%
March 31, 2024 26.81%
December 31, 2023 37.95%
September 30, 2023 41.72%
June 30, 2023 38.81%
March 31, 2023 26.59%
December 31, 2022 9.45%
September 30, 2022 2.35%
June 30, 2022 16.57%
March 31, 2022 13.12%
December 31, 2021 26.49%
September 30, 2021 10.77%
June 30, 2021 20.05%
March 31, 2021 10.96%
December 31, 2020 24.58%
September 30, 2020 23.17%
June 30, 2020 13.07%
Date Value
March 31, 2020 10.28%
December 31, 2019 -2.76%
September 30, 2019 3.57%
June 30, 2019 18.26%
March 31, 2019 5.33%
December 31, 2018 5.40%
September 30, 2018 -1.69%
June 30, 2018 21.42%
March 31, 2018 3.37%
December 31, 2017 34.60%
September 30, 2017 -28.52%
June 30, 2017 -9.23%
March 31, 2017 26.61%
December 31, 2016 17.72%
September 30, 2016 36.71%
June 30, 2016 52.18%
March 31, 2016 -114.0%
December 31, 2015
September 30, 2015 44.55%
June 30, 2015 40.80%
March 31, 2015 45.66%
December 31, 2014 34.03%
September 30, 2014 34.76%
June 30, 2014 35.38%
March 31, 2014 39.90%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
NeoGenomics, Inc. 44.06%
Quest Diagnostics, Inc. 32.53%
Labcorp Holdings, Inc. 27.71%
OPKO Health, Inc. 37.32%
Psychemedics Corp. --

Gross Profit Margin (Quarterly) Related Metrics